Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
|
August 1, 2013
Pulmonary arterial hypertension and pregnancy
Demet Terek, Meral Kayikcioglu, Hakan Kultursay, et al.
Respiratory Research
|
May 27, 2022
Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study
Dragana M Jovanovic, Martina Šterclová, Nesrin Mogulkoc, et al.
Royal Society Open Science
|
August 14, 2025
Tube2FEM: a general-purpose highly automated pipeline for flow-related processes in (embedded) tubular objects
Hani Cheikh Sleiman, Kevin M Moerman, Diana C De Oliveira, et al.
Drug Safety
|
August 1, 2020
Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE
Abigél M Kolonics-Farkas, Martina Šterclová, Nesrin Mogulkoc, et al.
The Lancet. Respiratory Medicine
|
July 1, 2017
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
Kerri A Johannson, Irina Strâmbu, Claudia Ravaglia, et al.
Respiratory Medicine
|
August 27, 2020
The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis
Steven D Nathan, A Whitney Brown, Nesrin Mogulkoc, et al.
The Open Respiratory Medicine Journal
|
October 22, 2020
Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
Lisa Lancaster, Jonathan Goldin, Matthias Trampisch, et al.
Annals of Medicine
|
March 19, 2026
Statin use and its implications on survival and disease progression in the European MultiPartner idiopathic pulmonary fibrosis registry (EMPIRE)
David Lang, Bernd Lamprecht, Nesrin Mogulkoc, et al.
Journal of Thoracic Disease
|
May 25, 2026
Adverse side-effects of antifibrotic drugs in idiopathic pulmonary fibrosis-clarification of several points
Dragana Jovanovic, Nesrin Mogulkoc, Martina Sterclova, et al.
Journal of Thoracic Disease
|
January 12, 2026
Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosis
Dragana Jovanovic, Nesrin Mogulkoc, Martina Sterclova, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
|
August 1, 2013
Pulmonary arterial hypertension and pregnancy
Demet Terek, Meral Kayikcioglu, Hakan Kultursay, et al.
Respiratory Research
|
May 27, 2022
Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study
Dragana M Jovanovic, Martina Šterclová, Nesrin Mogulkoc, et al.
Royal Society Open Science
|
August 14, 2025
Tube2FEM: a general-purpose highly automated pipeline for flow-related processes in (embedded) tubular objects
Hani Cheikh Sleiman, Kevin M Moerman, Diana C De Oliveira, et al.
Drug Safety
|
August 1, 2020
Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE
Abigél M Kolonics-Farkas, Martina Šterclová, Nesrin Mogulkoc, et al.
The Lancet. Respiratory Medicine
|
July 1, 2017
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
Kerri A Johannson, Irina Strâmbu, Claudia Ravaglia, et al.
Respiratory Medicine
|
August 27, 2020
The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis
Steven D Nathan, A Whitney Brown, Nesrin Mogulkoc, et al.
The Open Respiratory Medicine Journal
|
October 22, 2020
Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
Lisa Lancaster, Jonathan Goldin, Matthias Trampisch, et al.
Annals of Medicine
|
March 19, 2026
Statin use and its implications on survival and disease progression in the European MultiPartner idiopathic pulmonary fibrosis registry (EMPIRE)
David Lang, Bernd Lamprecht, Nesrin Mogulkoc, et al.
Journal of Thoracic Disease
|
May 25, 2026
Adverse side-effects of antifibrotic drugs in idiopathic pulmonary fibrosis-clarification of several points
Dragana Jovanovic, Nesrin Mogulkoc, Martina Sterclova, et al.
Journal of Thoracic Disease
|
January 12, 2026
Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosis
Dragana Jovanovic, Nesrin Mogulkoc, Martina Sterclova, et al.
Page
of 6